🔗 Permalink

Inventor profile of:

Ralf Hosse

City:

Cham

Country:

Switzerland

Published Applications:

Last publication date:

2026-05-07

Top Assignees for applications by Ralf Hosse

The entities that hold a legal rights for patent applications filed by inventor Hosse Ralf:

ROCHE GLYCART AG 34 Schlieren, Switzerland
HOFFMANN-LA ROCHE INC. 5 Little Falls, NJ United States
Roche GlycArt AG 3 , Switzerland
Roche Glycart AG 2 Schilieren, Switzerland
Roche Glycart AG 2 Schileren, Switzerland
ENGMAB SÀRL 2 Boudry, Switzerland
BRISTOL-MYERS SQUIBB COMPANY 1 Princeton, NJ United States
Roche Glyeart AG 1 Schlieren, Switzerland
ENGMAB AG 1 Wilen, Switzerland
ENGMAB AG 1 Pfäffikon, Switzerland
ENGMAB SARL 1 Boudry, Switzerland

Recent patent applications by Hosse Ralf

Ralf Hosse from Cham, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07

US20260125470A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#2 | 2026-04-30

US20260116973A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#3 | 2023-03-09

US20230076791A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#4 | 2022-09-08

US20220281995A1

Chemistry; metallurgy

Anti-FAP antibodies and methods of use

#5 | 2022-08-04

US20220242971A1

Chemistry; metallurgy

NOVEL IMMUNOCONJUGATES

#6 | 2022-07-14

US20220220224A1

Chemistry; metallurgy

T cell activating bispecific antigen binding molecules

#7 | 2022-07-07

US20220213224A1

Chemistry; metallurgy

T cell activating bispecific antigen binding molecules

#8 | 2022-03-03

US20220064296A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#9 | 2022-01-06

US20220002441A1

Chemistry; metallurgy

ANTI-CEA ANTIBODIES

#10 | 2021-08-19

US20210253704A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#11 | 2021-08-19

US20210253703A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#12 | 2021-04-08

US20210101979A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#13 | 2021-03-11

US20210070873A1

Chemistry; metallurgy

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

#14 | 2020-12-10

US20200385470A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#15 | 2020-08-13

US20200255521A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

#16 | 2020-06-04

US20200172633A1

Chemistry; metallurgy

COMMON LIGHT CHAINS AND METHODS OF USE

#17 | 2020-06-04

US20200172591A1

Chemistry; metallurgy

Interleukin-2 fusion proteins and uses thereof

#18 | 2020-03-12

US20200079873A1

Chemistry; metallurgy

Anti-FAP antibodies and methods of use

#19 | 2019-10-24

US20190322765A1

Chemistry; metallurgy

MUTANT INTERLEUKIN-2 POLYPEPTIDES

#20 | 2019-10-24

US20190322763A1

Chemistry; metallurgy

NOVEL IMMUNOCONJUGATES

#21 | 2019-10-17

US20190315883A1

Chemistry; metallurgy

Immunoconjugates

#22 | 2019-06-20

US20190185583A1

Chemistry; metallurgy

ANTI-CEA ANTIBODIES

#23 | 2019-06-13

US20190177413A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#24 | 2019-03-14

US20190077881A1

Chemistry; metallurgy

Mutant interleukin-2 polypeptides

#25 | 2019-02-28

US20190062453A1

Chemistry; metallurgy

Antibodies specific for DR5 and methods of use

#26 | 2019-01-31

US20190031784A1

Chemistry; metallurgy

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES

#27 | 2019-01-03

US20190002565A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#28 | 2019-01-03

US20190002564A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#29 | 2018-11-01

US20180312589A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#30 | 2018-08-09

US20180222991A1

Chemistry; metallurgy

Method for the selection of antibodies against BCMA

#31 | 2018-05-24

US20180142037A1

Chemistry; metallurgy

Mutant interleukin-2 polypeptides

#32 | 2018-03-22

US20180079827A1

Chemistry; metallurgy

ANTI-CEA ANTIBODIES

#33 | 2018-01-11

US20180009868A1

Chemistry; metallurgy

Interleukin-2 fusion proteins and uses thereof

#34 | 2017-10-26

US20170306044A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

#35 | 2017-10-26

US20170306036A1

Chemistry; metallurgy

Bispecific antibodies against CD3ϵ and BCMA

#36 | 2017-10-26

US20170306018A1

Chemistry; metallurgy

Bispecific antibodies against CD3EPSILON and ROR1

#37 | 2017-09-07

US20170253670A1

Chemistry; metallurgy

COMMON LIGHT CHAINS AND METHODS OF USE

#38 | 2017-03-30

US20170088631A1

Chemistry; metallurgy

Immunoconjugates

#39 | 2016-11-24

US20160340413A1

Chemistry; metallurgy

Interleukin-10 fusion proteins and uses thereof

#40 | 2016-10-13

US20160297881A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1

#41 | 2016-09-15

US20160264651A1

Chemistry; metallurgy

ANTI-TENASCIN-C A2 ANTIBODIES AND METHODS OF USE

#42 | 2016-09-15

US20160263240A1

Human necessities

Immunoconjugates

#43 | 2016-08-11

US20160229923A1

Chemistry; metallurgy

ANTI-CEA ANTIBODIES

#44 | 2016-07-21

US20160208019A1

Chemistry; metallurgy

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES

#45 | 2016-07-21

US20160208017A1

Chemistry; metallurgy

Mutant interleukin-2 polypeptides

#46 | 2016-03-31

US20160090407A1

Chemistry; metallurgy

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

#47 | 2016-03-03

US20160060357A1

Chemistry; metallurgy

Anti-FAP antibodies and methods of use

#48 | 2016-03-03

US20160060356A1

Chemistry; metallurgy

Anti-FAP antibodies and methods of use

#49 | 2015-12-31

US20150376287A1

Chemistry; metallurgy

Bispecific antibodies against CD3 and BCMA

#50 | 2015-12-24

US20150368351A1

Chemistry; metallurgy

Method for the selection of antibodies against BCMA

#51 | 2015-08-06

US20150218260A1

Chemistry; metallurgy

Interleukin-2 fusion proteins and uses thereof

#52 | 2015-08-06

US20150218244A1

Chemistry; metallurgy

INTERLEUKIN-10 FUSION PROTEINS AND USES THEREOF

#53 | 2014-12-18

US20140370019A1

Chemistry; metallurgy

Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5

#54 | 2014-08-28

US20140242083A1

Chemistry; metallurgy

ANTI-MCSP ANTIBODIES

#55 | 2014-08-28

US20140242079A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#56 | 2014-07-31

US20140212408A1

Chemistry; metallurgy

Anti-CEA antibodies

#57 | 2014-07-10

US20140193415A1

Chemistry; metallurgy

Bispecific anti-EGFR/anti IGF-1R antibodies

#58 | 2014-02-13

US20140044675A1

Chemistry; metallurgy

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

#59 | 2014-02-13

US20140044674A1

Chemistry; metallurgy

Interleukin-10 fusion proteins

#60 | 2012-11-01

US20120276125A1

Chemistry; metallurgy

Immunoconjugates

#61 | 2012-10-04

US20120251529A1

Chemistry; metallurgy

Anti-CEA antibodies

#62 | 2012-09-27

US20120244112A1

Chemistry; metallurgy

Mutant interleukin-2 polypeptides

#63 | 2012-05-24

US20120128591A1

Chemistry; metallurgy

Anti-FAP antibodies and methods of use

#64 | 2012-02-16

US20120039807A1

Chemistry; metallurgy

Anti-tenascin-C A2 antibodies and methods of use

InventorID:

649777 ⎘